SCHEMBL9963585

SCHEMBL9963585

Cc1c2nc(NCC(=O)N3CCCCC3)sc2cc2sc(NCC(=O)N3CCN(C4CCCC4)CC3)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
GRIN2B Q13224 1/20 0.45
PTGS2 P35354 3/20 0.44
TP53 P04637 1/20 0.44
ALDH1A1 P00352 7/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PHGDH O43175 1/20 0.38
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.38
G6PD P11413 1/20 0.38
CACNA1B Q00975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963580 0.97 ACHE (0.45) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963550 0.93 ACHE (0.42) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963572 0.93 TP53 (0.51) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963629 0.92 ACHE (0.42) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963549 0.92 ACHE (0.46) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963616 0.92 MAPT (0.42) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963481 0.91 ACHE (0.41) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963485 0.91 ACHE (0.41) BCHEACHEGRIN2BPTGS2TP53
SCHEMBL9963557 0.91 NPC1 (0.46) BCHEACHEGRIN2BTP53ALDH1A1
SCHEMBL9963567 0.91 ACHE (0.41) BCHEACHEGRIN2BPTGS2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 BCHE 3319/4885ACHE 1479/4885GRIN2B 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.